Haahr H - Search Results

1

Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial.

Heise T, Zijlstra E, Nosek L, Rikte T, Haahr H. Heise T, et al. Among authors: haahr h. Diabetes Obes Metab. 2017 Feb;19(2):208-215. doi: 10.1111/dom.12803. Epub 2016 Nov 14. Diabetes Obes Metab. 2017. PMID: 27709762 Free PMC article. Clinical Trial.

2

Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart.

Vague P, Selam JL, Skeie S, De Leeuw I, Elte JW, Haahr H, Kristensen A, Draeger E. Vague P, et al. Among authors: haahr h. Diabetes Care. 2003 Mar;26(3):590-6. doi: 10.2337/diacare.26.3.590. Diabetes Care. 2003. PMID: 12610006 Clinical Trial.

3

Time-action profile of insulin detemir and NPH insulin in patients with type 2 diabetes from different ethnic groups.

Hompesch M, Troupin B, Heise T, Elbroend B, Endahl L, Haahr H, Heinemann L. Hompesch M, et al. Among authors: haahr h. Diabetes Obes Metab. 2006 Sep;8(5):568-73. doi: 10.1111/j.1463-1326.2006.00643.x. Diabetes Obes Metab. 2006. PMID: 16918592 Clinical Trial.

4

Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double-blind, controlled trial.

Danne T, Datz N, Endahl L, Haahr H, Nestoris C, Westergaard L, Fjording MS, Kordonouri O. Danne T, et al. Among authors: haahr h. Pediatr Diabetes. 2008 Dec;9(6):554-60. doi: 10.1111/j.1399-5448.2008.00443.x. Epub 2008 Aug 27. Pediatr Diabetes. 2008. PMID: 18761644 Clinical Trial.

5

Biphasic insulin aspart 30/70: pharmacokinetics and pharmacodynamics compared with once-daily biphasic human insulin and Basal-bolus therapy.

Heise T, Heinemann L, Hövelmann U, Brauns B, Nosek L, Haahr HL, Olsen KJ. Heise T, et al. Diabetes Care. 2009 Aug;32(8):1431-3. doi: 10.2337/dc09-0097. Epub 2009 Jun 1. Diabetes Care. 2009. PMID: 19487640 Free PMC article.

6

Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes.

Heise T, Hermanski L, Nosek L, Feldman A, Rasmussen S, Haahr H. Heise T, et al. Among authors: haahr h. Diabetes Obes Metab. 2012 Sep;14(9):859-64. doi: 10.1111/j.1463-1326.2012.01627.x. Epub 2012 Jun 7. Diabetes Obes Metab. 2012. PMID: 22594461 Free article. Clinical Trial.

7

Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes.

Heise T, Nosek L, Bøttcher SG, Hastrup H, Haahr H. Heise T, et al. Among authors: haahr h. Diabetes Obes Metab. 2012 Oct;14(10):944-50. doi: 10.1111/j.1463-1326.2012.01638.x. Epub 2012 Jul 10. Diabetes Obes Metab. 2012. PMID: 22726241 Free article. Clinical Trial.

8

Insulin degludec's ultra-long pharmacokinetic properties observed in adults are retained in children and adolescents with type 1 diabetes.

Biester T, Blaesig S, Remus K, Aschemeier B, Kordonouri O, Granhall C, Søndergaard F, Kristensen NR, Haahr H, Danne T. Biester T, et al. Among authors: haahr h. Pediatr Diabetes. 2014 Feb;15(1):27-33. doi: 10.1111/pedi.12116. Pediatr Diabetes. 2014. PMID: 24467565 Clinical Trial.

9

Pharmacokinetic and pharmacodynamic responses of insulin degludec in African American, white, and Hispanic/Latino patients with type 2 diabetes mellitus.

Hompesch M, Morrow L, Watkins E, Roepstorff C, Thomsen HF, Haahr H. Hompesch M, et al. Among authors: haahr h. Clin Ther. 2014 Apr 1;36(4):507-15. doi: 10.1016/j.clinthera.2013.12.014. Epub 2014 Feb 5. Clin Ther. 2014. PMID: 24508419 Free article. Clinical Trial.

10

Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus.

Heise T, Nosek L, Roepstorff C, Chenji S, Klein O, Haahr H. Heise T, et al. Among authors: haahr h. Diabetes Ther. 2014 Jun;5(1):255-65. doi: 10.1007/s13300-014-0070-2. Epub 2014 Jun 3. Diabetes Ther. 2014. PMID: 24888255 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters